Contact
Please use this form to send email to PR contact of this press release:
Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial
TO: